Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Healthcare News.
Press releases published on May 27, 2025
Innovation in Motion: Soroka Medical Center Earns Top 2025 Urban Planning Prize
EIN Presswire
·
May 27, 2025
BE'ER SHEVA, ISRAEL, May 27, 2025 /EINPresswire.com/ -- The borders of municipal hospitals are often marked by perimeter fences designed to ensure safety and control for patients and staff. Yet these boundaries also physically and symbolically separate …
SONSIEL and The DAISY Foundation Celebrate Nurse Innovation at THInC with Inaugural DAISY Awards
EIN Presswire
·
May 27, 2025
BOSTON, MA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- In a landmark moment for nursing innovation and recognition, the Society of Nurse Scientists, Innovators, Entrepreneurs, and Leaders (SONSIEL) and The DAISY Foundation proudly presented the …
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
GlobeNewswire
·
May 27, 2025
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to …
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
GlobeNewswire
·
May 27, 2025
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
GlobeNewswire
·
May 27, 2025
BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases BD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targets Collaboration builds on …